I'd much prefer to see a roadshow to HNW/UHNW individuals in the US and EU/Switzerland where a solid development plan was laid out in combination with a $50mil-$100mil raise.
I don't mind more dilution provided the funds received are from the right sort of investor and I'd much prefer to see a dilution in power of some of the existing 'so called' cornerstone investors.
IMHO you can only get the (say 2x?) bump in share price for a takeover/merger once, it's be great to see that happen off a much higher base and not give away control/equity in the hopes the a NASDAQ listing will see a positive re-rate.
Wolgen who heads up $CUV has a 21 point checklist that he is looking to tick off before listing on NASDAQ, he has reviewed the performance of the healthcare/biotech players in the index and listing is not a sure thing for positive re-rate.
(All IMHO, pls DYOR)![]()
- Forums
- ASX - By Stock
- AVR
- News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To..., page-57
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.71 |
Change
0.010(0.06%) |
Mkt cap ! $301.9M |
Open | High | Low | Value | Volume |
$16.00 | $16.01 | $15.49 | $3.254M | 230.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $15.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.20 | 700 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 15.700 |
1 | 437 | 15.550 |
1 | 296 | 15.510 |
2 | 1150 | 15.500 |
2 | 652 | 15.490 |
Price($) | Vol. | No. |
---|---|---|
16.200 | 700 | 2 |
16.500 | 63 | 1 |
16.600 | 500 | 1 |
17.000 | 550 | 1 |
17.100 | 900 | 1 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |